Editor's note: From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

Jiuxiang Zhu, Jui Wen Huang, Ping Hui Tseng, Ya Ting Yang, Joseph Fowble, Chung Wai Shiau, Yeng Jeng Shaw, Samuel K. Kulp, Ching Shih Chen

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish
Pages (from-to)1716
Number of pages1
JournalCancer Research
Issue number7
StatePublished - 1 Apr 2019

Cite this